Rigrodsky & Long, P.A. Investigates Emergent Group Inc. Buyout

  • Do you own Emergent Group Inc. common stock?
  • Did you purchase your shares prior to February 7, 2011?
  • Do you feel the Company's sale to Universal Hospital Services is fair?
  • Do you want to discuss your rights?

If the answer to these questions is "yes," please contact the deal lawyers at Rigrodsky & Long, P.A. ("R & L") today to schedule a FREE consultation. Just call us, or fill out our contact form so that we can call at your convenience. Your consultation will not create any obligation to use our services at any time.

Contact R & L today to be sure your best interests are being protected.

R & L is national law firm with decades of combined legal experience. R & L is investigating potential claims against the board of directors of Emergent Group Inc. concerning possible breaches of fiduciary duty and other violations of law related to the Company’s entry into an agreement to be acquired and taken private by Universal Hospital Services, Inc. in a transaction with a total enterprise value of approximately $70 million.

Click here to read the full press release.

Rigrodsky & Long, P.A. Investigates Emergent Group Inc. Buyout

Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of Emergent Group Inc. (“Emergent” or the “Company”) (NYSE Amex: LZR) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s entry into an agreement to be acquired and taken private by Universal Hospital Services, Inc. (“UHS”) in a transaction with a total enterprise value of approximately $70 million (including the assumption of debt).

Under the proposed agreement, UHS will make a cash tender offer of $8.46 per share for all outstanding shares of Emergent after a “go-shop” period of 21 days. According to the press release announcing the deal, assuming that UHS acquires at least 65% of the outstanding shares on a fully diluted basis, UHS intends to promptly take appropriate action to merge Emergent into a wholly-owned UHS subsidiary and pay all-non-tendering holders of Emergent the same consideration per share as paid in the tender offer.

The investigation concerns whether Emergent’s board of directors are adequately shopping the Company and working to obtain the best price possible for Emergent’s shareholders before entering into the agreement with UHS. Moreover, the directors and executive officers of Emergent, holding in the aggregate approximately 47% of the Company’s outstanding shares, have agreed to tender their shares in the tender offer unless it is terminated as a result of a superior proposal.

If you own the common stock of Emergent and purchased your shares before February 7, 2011, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky, Esquire or Noah R. Wortman, Case Development Director, of Rigrodsky & Long, P.A., 919 N. Market Street, Suite 980, Wilmington, Delaware, by telephone at (888) 969-4242, or by e-mail to info@rigrodskylong.com.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

R & L, with offices in Delaware and New York, litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.

Learn more about R&L:  Visit Our WebsiteOur Firm  |  Our Practice Areas  |  FAQ's

Fill out the form below or call us toll-free at 888-969-4242, for a FREE no-obligation consultation.